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Abstract 
 A quantitative structure-activity relationship (QSAR) study on a set 
of 36 structurally-similar 8-methylquinolones was performed using a large 
pool of theoretical molecular descriptors. The molecular structures of the 
compounds were pre-optimized using molecular mechanics (MM2). Full 
optimization was done with the density functional theory (DFT) using 
Becke’s three-parameter hybrid functional with LYP correlation functional  
in combination with the standard pople’s basis set 6311G*. HOMO and 
LUMO energies, dipole moment, total energy and many other properties 
served as quantum-chemical descriptors.  The GA-MLRA technique was 
used to select the most significant descriptors and to generate a linear model 
for predicting the biological activity, Minimal Inhibitory Concentration 
(MIC), treated as negative decade logarithm, (pMIC). The best model was 
obtained with   R2=0.90323   . The model was tested internally using the 
leave-one-out (LOO) cross validation procedure on the training set and 
validated against the external validation set (Q2 LOO = 0.83115  and R2Pred = 
0.78708  ). The Y-scrambling/randomization validation also confirmed the 
statistical significance of the model. Leverage approach was used to define 
the applicability domain of the model. This validated model could be used to 
design new potential drug candidates, within the 8-methylquinolone family, 
with high activity against tuberculosis.  
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Introduction 
Background of the Study 
 Tuberculosis (TB) is a disease of antiquity which is thought to have 
evolved sometime between the seventh and sixth millennia BC   
(Manchester. 1984). This disease has been recognized for thousands of years 
and the etiological agent has been identified since earliest days of medical 
biology, however, the global burden of TB  has continue to loom as one of 
the largest among infectious diseases, with an enormous toll in morbidity and 
mortality. (Leonard, 2009).  This disease which is caused by various strains 
of mycobacterium, usually mycobacterium tuberculosis ( Luo 2012)  has 
been reported to be the leading cause of death from a single infectious agent, 
after the human immuno deficiency virus (HIV).  (WHO, 2014). Currently 
one-third of the world is believe to harbor the latent form of mycobacterium 
tuberculosis, with a lifelong risk of activation and disease development, 
particularly in people co-infected with HIV. (Anil, 2011) The World Health 
Organization (2014) reported 1.5 million deaths from tuberculosis globally in 
2013. Ironically, available therapeutic agents are highly efficacious in TB, 
with cure exceeding 95% during clinical trials (Frieden, 2003). The natural 
question then is; why has the control of TB been so problematic? The answer 
lies in the indolent clinical nature of the disease, which needs prolong 
complex therapy and the unusual microbiological properties of the pathogen. 
(Leonard,2009). 
 The treatment of TB is quite long ,taking approximately 6-9months 
(Blumberg et al., 2003). The prolonged duration of the treatment as well as 
the toxicity and the poor patience compliance are risk factors which 
frequently lead to selection of drug resistant and very often deadly multi-
drug resistant strains. This increasing problem of multi-drug resistant strains 
is the major challenge for the investigation and designs of novel drug 
candidates which are not only active against stable drug resistant 
m.tuberculosis but also shorten the length of therapy. 
 
Quinolones 
 In the search for new anti- tubercular agents, quinolones are 
particularly interesting. This is because they potentially offer many of the 
attributes of an ideal antibiotic, combining high potency, a broad spectrum of 
activity, good bioavailability, oral and intravenous formulations, high serum 
levels, a large volume of distribution indicating concentration in tissues and a 
potentially low incidence of side-effects.( Emami , Shafiee  and Foroumadi 
,2005) 
 The first quinolone, nalidixic acid, (1-ethyl-7-methyl-1,4-dihydro-4-
oxo-1,8- naphthyridine-3-carboxilic acid , was isolated as a by-product of the 
synthesis of chloroquine  by George Lesher and his coworkers in 1962,it  
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was found to be effective in the treatment of treatment of urinary tract 
infections (UTIs) ( Lescher et al, 1962; Norris S. and Mandell,1988 ). 
 Quinolones act by blocking bacterial DNA synthesis through 
inhibition of bacterial topoisomerase-II (DNA gyrase) and topoisomerase IV. 
Inhibition of DNA gyrase prevents the relaxation of positively super coiled 
DNA that is required for normal transcription and replication. Inhibition of 
topoisomerase-IV interferes with separation of replicated chromosomal DNA 
into the respective daughter cells during cell division (Alangaden and Lerner 
,1997, Flamm et al ,1995).  Quinolone agents basically possess a bicyclic 
aromatic core; this can contain a carbon at the 8-position, yielding a true 
quinolone, or a nitrogen, which provides a ring system technically termed a 
naphthyridone (Figure 1). 
.           
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Fig 1. Quinolone and Naphthyridone nuclei; general structural features required for 
antibacterial activity 
 
 It is common practice, however, for both quinolone and 
naphthyridone structures to be classified as “quinolone antibacterial agents.” 
The pyridone ring on the right-hand side is an essential necessity for 
Antibacterial activity. (Bright and Gootzy, 2000) 
 
Experimental procedure  
Data set  
 The data set contains 36 derivatives of 1-(cyclopropyl/2,4-
difluorophenyl/tert-butyl)-1,4-dihydro-8-methyl-6-nitro-4-oxo-7-(substituted 
secondary amino)quinoline-3-carboxylic acids  with different substitution on 
position 2 and 5. The in vitro antimycobacterial activity (MIC) of the 
molecules against Mycobacterium Tuberculosis strain H37Rv determined by 
agar dilution method for the determination of MIC in duplicates (NCCLS, 
1995), were taken from the work of Senthilkumar et al., (2009). Table 1 lists 
the chemical structure and the anti-tuberculosis activity (pMIC) of the 
molecules used in this study. 
 The inhibitory data (MIC in µM)  was converted to negative 
logarithmic dose in mole (pMIC) because a QSAR is a linear free energy 
relationship, and from the van’t Hoff isotherm, free energy change during a 
process is proportional to the logarithm of the rate or equilibrium constant of 
the process (∆G = 2.303 RTlog K ).  (Gupta et al., 2007) 
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Table 1
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… continued Table 1 
ID R2 R1 pMIC 
1e 
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H3C CH3
CH3
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CO
NHC CH3
CH3
CH3
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2e 
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3e F
F  
4.07 
 
1f 
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N
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2f 
F
F  
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3f 
 
6.38 
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CH2
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2g 
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… continued Table 1 
ID R2 R1 pMIC 
1i 
 
 
N
O
CH3
H3C
 
 
 
 
 
 
5.70 
 
2i 
C
H3C CH3
CH3
 
5.16 
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… continued Table 1 
ID R2 R1 pMIC 
1l 
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3l 
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1n 
 
 
 
 
N
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2n 
F
F  
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3n 
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H3C CH3
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F
F  
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… continued Table 1 
ID R2 R1 pMIC 
1p 
 
N
N
 
5.16 
 
2p 
C
H3C CH3
CH3
 
4.58 
 
1q 
 
N
N
O
O
O  
5.53 
 
*These are compounds in the external Validation Set 
 
Geometry optimization and calculation of quantum-chemical 
descriptors 
 The molecular structures previously collected were in 2D format 
(ChemBioOffice 2D sketch (*.mol)). Using the SPARTAN “14 v 1.1.0  
software package (2013) each structure was subsequently resketched in a 3D 
environment, checked by visual inspection in order to ensure that the 3D 
geometry is correct, and saved as SAPRTAN input file format (*.spartan) for 
geometry optimization. The molecular geometry of all model structures were 
subjected to energy minimization using molecular mechanics (MM2) and 
then re-optimized  using the density functional theory (DFT) with Becke’s 
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three-parameter hybrid functional ( Becke,1988) using LYP correlation 
functional  ( Lee , Yang and  Parr 1988 ) . The standard Pople’s 6-311G*   
basis set was used. All calculations were carried out using the SPARTAN 
14” v 1.1.0 (2013) suite of programs. Several descriptors evaluated by 
quantum- chemical calculations as described above, were used in this study. 
These descriptors include the Highest occupied molecular orbital, HOMO; 
Lowest unoccupied molecular orbital, LUMO; Energy gap ,Total energy, 
total dipole moment, polarizability, ovality Ionization energy (IP) , electron 
affinity(EA), Global hardness (𝜂) ,Chemical potential (µ) ,global 
electrophilicity index (𝜔) and total softness S   
 
Calculation of 0D,1D,2D and 3D descriptors 
 The 0D, 1D,2D, 3D molecular descriptors for each compound of the 
training/validation were calculated using PADEL  (Yap, 2001) software 
package. The final pool of the calculated 0D, 1D, 2D and 3D theoretical 
molecular descriptors, 1537 in total can be separated into sixty-one classes:  
 Acidic group count, ALOGP, APol , Aromatic atoms count, 
Aromatic bonds count, Atom count, Autocorrelation. Barysz matrix, Basic 
group count, BCUT, Bond count, BPol ,Burden modified eigenvalues, 
Carbontypes, Chi chain, Chi cluster, Chi path cluster, Chi path, 
Constitutional, Crippen logP and MR, Detour matrix, Eccentric connectivity 
index, Atom type electrotopological state, Extended topochemical atom, 
FMFDescriptor, Fragment complexity, Hbond acceptor count, Hbond donor 
count, Hybridization ratio, Information content, Kappa shape indices, 
Largest chain, Largest Pi system, Longest aliphatic chain, MannholdLogP, 
McGowan volume, Molecular distance edge, Molecular linear free energy 
relation, Path counts, Petitjean number, Ringcount, Rotatable bonds count, 
Rule of five, Topological, Topological charge,Topological distance matrix, 
Topological polar surface area, Van der Waals volume, Vertex adjacency 
information (magnitude),Walk counts, Weight, Weighted path, Wiener 
numbers, XLogP, Zagreb index,3D autocorrelation, Charged partial surface 
area, Gravitational index, Moment of inertia, Petitjean shape index, RDF. 
 The preprocessing of the independent variables (i.e., descriptors) was 
done by removing invariable (constant column) and cross-correlated 
descriptors (with R2 = 0.75), this left  a  total of 316 descriptors which were 
then individually normalized to the [0, 1] range, and used for QSAR 
analysis. 
 
Development of a Quantitative Structure- Activity Relationships Model  
 Initially the dataset was divided into  training  and test sets using the 
random division approach. This division procedure resulted in 28 compounds 
in the training set and 8 compounds in the test set (see Table 1). The 
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selection of significant descriptors, which constructs a relationship between 
the biological activity of the data and its molecular structures, is an important 
step in QSAR modeling. For this purpose the variable selection genetic 
algorithm (GA) and Multiple Linear Regression Analysis (MLRA) methods 
were used.  
 The GA has been applied widely in many areas, and specifically, in 
recent studies as a powerful tool to address many problems in 
cheminformatics.GA is an optimization algorithm based on the evolutionary 
mechanisms as proposed by Darwin, it uses random mutation, crossover and 
selection procedures to produce better models or solutions from an originally 
random starting population or sample. (Davis, 1991; Devillers,1996) 
 The MLR, also known as linear free-energy relationship method  is 
an extension of simple linear regression analysis to more than one dimension 
(Berk, 2003)  . MLR generates QSAR equations by performing standard 
multivariable regression calculations to identify the dependence of a drug 
property on any or all of the descriptors under investigation. (Thangapandian 
et al., 2012) 
 The combination of the GA-MLRA technique was employed for 
preliminary model selection, as implemented in the BuildQSAR (De Oliveira 
and Gaudio, 2001) software.   
 The GA began with a population  of 100 random models, 1000 
iterations to evolution, and the mutation probability of 35% .Initially several 
models which contain between  1–5 variables were selected. A final set of 
three models consisting of two 5-parameter and one 4-parameter models was 
selected for further analysis, based on their high squared correlation 
coefficient R2, low standard error s, high Fisher coefficient F.  A detailed 
statistical analysis of the selected models was carried out using Material 
Studio Software 7.0 
 
Model Validation 
 Internal Validation - The three models were internally validated 
using the cross-validation leave-one-out procedure. In the leave-one-out 
(LOO) method of cross validation, the process of removing a molecule, and 
creating and validating the model against the individual molecules is 
performed for the entire training set. Once complete, the mean is taken of all 
the Q2 values and reported (Ravichandran et al., 2011)  
 The Q2LOO  was calculated using the equation   (10)   (Consonni, 
Ballabio, and Todeschini,2009) 
𝑄𝑡𝑟 2 = 1 − ∑ �𝑦𝑖,𝑒𝑥𝑝 − 𝑦𝑖,𝑝𝑟𝑒𝑑�2𝑁𝑡𝑟𝑖=1∑ �𝑦𝑖,𝑒𝑥𝑝−𝑦�𝑖,𝑒𝑥𝑝�2𝑁𝑡𝑟𝑖=1 …………. (10) 
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 Where   Ntr is the total number of training set objects; 𝑦𝑖,𝑒𝑥𝑝  
and 𝑦𝑖,𝑝𝑟𝑒𝑑 are the experimental and predicted values, respectively; 𝑦�𝑖,𝑒𝑥𝑝 is 
the average response value of the training set.  
 
External Validation    
 The models were externally validated by testing the previously 
excluded compounds which form the test set. The value of R2Pred which gives 
an indication of the predictive power of a model was calculated   using 
equation (11)   (Schüürmann et al., 2008) 
𝑅𝑃𝑟𝑒𝑑
2 = 1 − ∑ �𝑦𝑖,𝑒𝑥𝑝−𝑦𝑖,𝑝𝑟𝑒𝑑�2𝑁𝑒𝑥𝑡𝑖=1
∑ �𝑦𝑖,𝑒𝑥𝑝−𝑦�𝑖,𝑝𝑟𝑒𝑑�2𝑁𝑒𝑥𝑡𝑖=1    ………….. ( 11) 
where Next is the total number of external validation set objects; yi,exp and 
yi,pred are the experimental and predicted values, respectively; 𝑦�𝑖,𝑝𝑟𝑒𝑑 is the 
average response value of the external validation set.  
 The selection of robust and well predictive QSAR models on the 
basis of only R2, Q2 and R2pred might mislead the search for the ideal 
predictive model, so additional statistical parameters have been suggested by 
Tropsha (2010) ; a model that must  be regarded as truly predictive  must 
satisfy the following conditions  
1. Q2 > 0.5  
2. R2pred  > 0.6 
3. |𝑅02 −  𝑅0,2| < 0.3 
      4      �|𝑅02− 𝑅0,2|
𝑅2
< 0.1�  and 0.85<k<1.15   or      [ (R2 - R'02)/R2)<0.1]  and  
0.85<k'<1.15  
 Where R is the correlation coefficient between the predicted and 
observed activities; R02   is coefficients of determination (predicted versus 
observed activities, and observed versus predicted activities R’0 2 for 
regressions through the origin); (iii) slopes k and k’ of regression lines 
through the origin. These additional statistical parameters were calculated for 
the selected models and the result summarized in table (4). The model with 
the highest R2Pred value was chosen as the final model.   
 
Robustness of QSAR Models     
 The final Model was validated by the Y-randomization 
(randomization of response). This is approach widely use to validate the 
robustness of QSAR models (Wold and Ericksson, 1995). It consists of 
rebuilding models using randomized activities of the training set and 
subsequent assessment of the model statistics. It is expected that models 
obtained for the training set with randomized activities should have 
significantly lower values of pMIC for the training set than the models built 
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using training set with real activities. If this condition is not satisfied, models 
built for this training set with real activities are not reliable and should be 
discarded.  
 In addition, the parameter R2p  (Roy ,2007) which penalize the model 
R2 for the difference between squared mean correlation coefficient (R2r) of 
the randomized models and squared correlation coefficient (R2) of the non-
randomized model given (Roy ,2007)  by eq ( 12 ) was also calculated for the 
model. 
𝑅𝑃 2 =  𝑅2 ∗  �1 −�|𝑅2 − 𝑅𝑟2|� …….. (12) 
A value of 𝑅𝑃 2   greater than 0.5 may be taken as an indicator of model 
acceptability 
 
Applicability domain 
 The applicability domain of a (Q)SAR model is a theoretical region 
in chemical space, defined by the model descriptors and modeled response, 
and thus by the nature of the chemicals in the training set, as represented in 
each model by specific molecular descriptors. Thus only the predictions for 
chemicals falling within this domain can be considered reliable and not 
model extrapolations (Gramatica, 2007).  Without the restriction placed by 
the applicability domain, QSAR models can predict the activity of any 
compound even if such a compound is structurally different from those 
included in the training set. This would lead to unreasonable extrapolation of 
the model in chemistry space and therefore heighten the chances of 
inaccurate predictions.  Thus for a QSAR model to give reliable outcome, its 
applicability domain must de be define. 
 In this study, the applicability domain of the final model was 
calculated by the leverage approach (Eriksson et al, 2003),The leverage 
value of every compound was calculated and plotted against the standardized 
residuals (William plot). This method offers a graphical assessment of the 
leverage values (hii) as a function of the standardized cross validated 
residuals and it is suitable not only for detection of the structurally-
influential outliers, but also for determination of the response outliers 
(Gramatica, 2007). The leverage is defined as a compound’s distance from 
the centroid of X. Mathematically, the leverage (hii) of a given compound in 
the multidimensional descriptor space, can be calculated as (Eq. 13)      
  ℎ𝑖𝑖 = 𝑥𝑖𝑇(𝑋𝑇𝑋)−1𝑥𝑖   ……………….. (13) 
Where 𝑥𝑖  the descriptor row matrix of the compound under 
consideration and X is is the multidimensional matrix carrying the structural 
information (calculated molecular descriptors) for each training set 
compound. 
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 The model predictions should be referred as unreliable for those 
compounds for which hii diagonal elements are greater than the cut-off 
leverage value (h*). These compounds are located far from the structural 
centroid of the model, and therefore could be referred as structurally-
influential outliers. The cut-off leverage value (h*) is usually defined by 
Eq. (14) 
ℎ∗ = 3(𝑃+1)
𝑛
  ………….(14) 
where  p is the total number of descriptors used for developing of the QSAR 
model, while n is the total number of the training set compounds. Moreover, 
the compounds for which the calculated standardized residual values are 
greater than three standard deviation units ( >±3σ ) could be considered as 
response outliers( Gramatica, 2007).  
 
Result and Discussion  
 This study was focused on developing a valid model that capable of 
predicting the activity of derivatives of 1-(cyclopropyl/2,4-
difluorophenyl/tert-butyl)-1,4-dihydro-8-methyl-6-nitro-4-oxo-7-(substituted 
secondary amino)quinoline-3-carboxylic acids  which could subsequently be 
used to design new potential drug candidates, with possible better activity . 
For this purpose a QSAR approach was utilized.  One of the most important 
steps in QSAR modeling is to define the number of independent variables in 
the model equation obtained. In this way the over- parameterization of the 
mathematical model as well as the chance correlation between the molecular 
descriptors is avoided (Topliss and Edwards, 1979). Since the modeling 
procedure started   with a pool of several theoretical molecular descriptors, a 
possibility exists to encounter a chance correlation in a case where the 
number of examined variables is higher than the number of observations. 
The GA  was applied to select  from the pool of calculated  descriptors, only 
the best combinations of  those most relevant for obtaining models with the 
highest predictive power for activity. Eventually the  GA-MLRA  to build 
different QSAR models.  
 Initially several 1-5 parameter models were generated, a set of three 
models, consisting of   two 5-parameter models and one 4-parameter model 
was selected for further analysis based on their high squared correlation 
coefficient R2, low standard error s and high Fisher coefficient F .The three 
models were validated internally using the Leave One Out technique (LOO) 
where their various Q2 LOO  were calculated. Also the models were externally 
validated by testing   their predictive performances   using the external 
validation set that were not used for model development. See table 2 for the 
statistical parameters as well as the internal and external validation 
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parameters,(Q2LOO),(R2Pred)  respectively of the three selected models.  Table 
3 compares the Observed verses Predicted activities of the selected models. 
 
Selected Models 
pMIC = 5.19(+/-0.05)  -0.37(+/-0.06) MATS4c -0.23(+/-0.06) VE3_Dzp 
+0.63(+/-0.06) SCH-3 -0.22(+/-0.05) PetitjeanNumber -0.15(+/-0.04) 
RDF95u………(1) 
pMIC = 5.20(+/-0.04)  -0.23(+/-0.06) AATSC5p -0.43(+/-0.05) MATS4c -
0.35(+/-0.06)VE3_Dzp +0.62(+/-0.05)SCH-3 -0.26(+/-0.05) 
PetitjeanNumber…….(2) 
pMIC = 5.26(+/-0.05)  -0.30(+/-0.06) MATS4c +0.69(+/-0.07) SCH-3 
+0.26(+/-0.07) ZMIC3 -0.30(+/-0.06) RDF10u……….(3) 
Table 2 Fitting Parameters For The Selected models 
S/N R2 R2adjs F s Q2LOO R2Pred SPress SDEP n k 
1. 0.88 0.85 31.62 0.26 0.82 0.77 2.17 0.28 28 5 
2 0.90 0.88 41.07 0.23 0.83 0.78 2.03 0.27 28 5 
3 0.85 0.82 32.38 0.28 0.78 0.57 2.66 0.31 28 4 
 
 Since the selection of a robust and well predictive QSA R model on 
the basis of only R2, Q2 and R2pred might be misleading, the selected models 
were subjected to further statistical analysis as suggested by Golbraikh and 
Tropsha, the result is summarized in table 4. From table 4 it can be seen that 
models 1 and model 2 both fulfilled all the Golbraikh and Tropsha criteria 
for a truly predictive model, but model 3 failed, as its R2pred of 0.57 is lower 
than the accepted value of 0.6.Finally model (2) was selected as the final 
model since it performed best at predicting the activities of the external 
validation set as indicated by the value of R2pred.  
Table 4 Golbraikh and Tropsha acceptable model criteria For  The Selected Models 
 
MODEL 
 
Q2 
 
R2 Pred 
 
|R 0 2 – 
R’0 2| 
 
[(R2 -R0 2)/ 
R2] 
 
[(R2 -R0 2)/ 
R2] 
 
k 
 
k’ 
1 0.82 0.77 0.08 0.00 0.10 0.99 1.01 
2 0.83 0.78 0.01 0.01 0.01 0.98 1.02 
3 0.78 0.57 0.02 0.09 0.12 0.96 1.04 
 
The mathematical equation of model (1)  is as follows: 
pMIC = 5.20(+/-0.04) -0.25(+/-0.06) AATSC5p -0.43(+/-0.05) MATS4c -
0.35(+/-0.06) VE3_Dzp +0.62(+/-0.05) SCH3 -  0.26(+/-0.05) 
PetitjeanNumber…….(2) 
 R2 = 0.90323   R2adjs  =  0.88123         F  =  41.0676      s =   0.2301      Q2LOO = 
0.83115        R2Pred     =    0.78708  SPress = 2.03242      SDEP   = 0.26942  n =  
28     
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 The high correlation coefficient R (0.91) indicates the susceptibility 
of descriptors (AATSC5p, MATS4c, VE3_Dzp, SCH-3 and SCH-3   ) to 
form the above model (2). Squared correlation coefficient (R2) of 0.903 
explains 90% variance in biological activity of the tested compounds. It also 
indicates the statistical significance >99.9% with F-values (41.0676). Cross-
validated square correlation coefficient (Q2) by LOO technique was 0.83115 
which showed a good internal predictive ability of the model. The model was 
also validated by applying the Y-randomization test. Several random shuffles 
of the Y vector were performed and the obtained results are in good 
agreement with the suggested limits (Eriksson et al., 2003). 
 The low R2 and Q2LOO values of the random models shown in  Table 
5 and the value of  𝑅𝑃 2 = 0.808101  (𝑅𝑃 2 ≥ 0.5)  indicates that there is no 
chance of correlation or structural dependency in the proposed model.  
Consequently model (2) can be considered as a perfect model with both high 
statistical significant and excellent predictive ability. 
Table 5  Y-Randomization Result 
Model R R2 Q2 
Original 0.95 0.90 0.83 
Random 1 0.41 0.17 -0.42 
Random 2 0.53 0.28 -0.35 
Random 3 0.48 0.23 -0.32 
Random 4 0.46 0.21 -0.35 
Random 5 0.51 0.26 -0.67 
Random 6 0.32 0.10 -1.03 
Random 7 0.24 0.04 -1.25 
Random 8 0.34 0.11 -0.54 
Random 9 0.64 0.41 -0.08 
Random 10 0.30 0.09 -0.94 
 
Random Models Parameters 
Average R :  0.42 
Average R2:  0.19   Average Q2:  -0.59    R2p = 0.81 
 It was observed that, AATSC5p, MATS4c , VE3_Dzp,  SCH-3 and 
PetitjeanNumber are the best descriptors in the establishment of the QSAR 
model for the class of compounds in this study. Table 6   shows the 
experimental and calculated activities of the training set while Fig 4  shows 
the corresponding plot of the experimental activities with the calculated 
ones.  
 Table 7   also shows the experimental and calculated activities of the 
external validation set and figure 5 captures the graphic correlation between 
them. 
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 The applicability domain (AD) of the five-descriptor linear model 
previously selected (Williams plot) was assessed utilizing the well known 
leverage approach (Fig. 3). Training set objects (28 compounds with 
experimental activity values) used in the model development are presented as 
solid dots, whereas the external validation set objects (9 compounds) as solid 
rectangles labeled with the corresponding number (ID signature). The 
analysis of AD for the training set objects shows that only one compound 
labeled with (ID20) signature can be identified as a typical 
 X-outlier (h > h* = 0.643 ). 
However the pMIC prediction of this compound was fairly good as can be 
seen in Table 6  
None of  the external validation set is a typical X-outliers with h > h*. Also 
no compound within the training as well as the external validation set is a 
typical Y-outlier since the cut off value for standard deviation is ±3.0σ 
 
Fig 3  Graphical representation (Williams plot) of the five- descriptor MLR model's 
applicability domain (AD) together with external validation set object 
 
Table6   Observed Activity versus Predicted Activity OF Model 2 
 
 
COMP. 
NO 
 
 
pMIC 
OBSERVED 
 
pMIC 
CALCULATED 
 
 
RESIDUAL 
 
 
STANDARD 
DEV. 
3 4.61 4.46 0.16 0.69 
4 5.54 5.49 0.05 0.23 
7 4.59 4.56 0.04 0.15 
14 4.63 4.67 -0.04 -0.16 
15 5.82 5.87 -0.04 -0.19 
16 4.58 4.78 -0.21 -0.90 
17 5.23 5.09 0.14 0.59 
18 6.38 6.00 0.37 1.62 
20 4.69 4.50 0.20 0.86 
22 4.60 4.93 -0.33 -1.45 
23 4.95 4.97 -0.02 -0.10 
24 6.41 6.09 0.32 1.37 
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25 5.70 5.86 -0.16 -0.71 
26 5.17 4.93 0.23 1.02 
27 4.81 4.62 0.19 0.81 
28 6.17 6.30 -0.13 -0.56 
31 6.08 6.11 -0.04 -0.16 
32 4.39 4.36 0.04 0.17 
33 4.59 4.98 -0.30 -1.72 
34 4.67 4.93 -0.26 -1.15 
35 4.62 4.97 -0.35 -1.51 
36 6.11 6.16 -0.05 -0.22 
39 6.08 5.98 0.10 0.43 
43 5.70 5.51 0.19 0.84 
44 4.87 4.91 -0.04 -0.17 
45 4.51 4.50 0.02 0.07 
49 5.16 5.41 -0.25 -1.09 
51 4.58 4.29 0.29 1.26 
 
Table 6 Observed Activity versus Predicted Activity For  Test Sets 
Name Yobs Ypred (Residual)2 (Yobs- Ybar)2 
1 5.20 5.60 0.16 0.00 
11 4.85 5.24 0.15 0.11 
12 5.74 5.38 0.13 0.31 
19 5.53 5.52 0.00 0.12 
47 5.18 4.91 0.07 0.00 
48 6.01 6.30 0.09 0.68 
53 5.53 5.70 0.03 0.12 
52 4.07 4.27 0.04 1.24 
 
Fig 4. The experimental vs. predicted pMIC values  For Training Sets using MLR method. 
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Fig 5 The experimental vs. predicted pMIC values  For Test Sets using MLR method 
 
 The correlation matrix for the descriptors present in all three models   
and   pMIC used in the present study is shown in Table 8. The sign of the 
correlation tells us whether the two variables are positively (more X means 
more Y) or negatively (more X means less Y) related. pMIC and SCH-3 had a 
good positive correlation (r=0.7533) and strongly associated with . However, 
the correlations for this descriptors considered as a single descriptor in the 
model was not sufficient to be considered significant in predicting anti-
tuberculosis activity 
Table 8  Correlation matrix among the descriptors 
 pMIC AATSC
5p 
MATS
4c 
VE3_D
zp 
SCH-3 Petitjea
n 
Number 
RDF9
5u 
RDF1
0u 
ZMI
C3 
pMIC 1         
AATSC5
p 
-0.37 1        
MATS4c -0.09 -0.15 1       
VE3_Dz
p 
0.04 -0.42 -0.35 1      
SCH-3 0.75 -0.38 0.32 0.11 1     
Petitjean 
Number 
-0.09 -0.07 -0.17 -0.07 0.11 1    
RDF95u -0.38 0.64 -0.06 -0.08 -0.21 -0.02 1   
RDF10u -0.30 0.35 -0.11 0.17 -0.13 -0.02 0.81 1  
ZMIC3 -0.26 0.12 -0.01 -0.13 -0.44 -0.34 0.33 0.53 1 
 
Description of the various descriptors in the Final Model. 
AATSC5p :Average centered Broto-Moreau autocorrelation - lag 5 / 
weighted by polarizabilities 
MATS4c: is the Moran autocorrelation - lag 4 / weighted by charges 
 VE3_Dzp: is the Logarithmic coefficient sum of the last eigenvector from 
Barysz matrix / weighted by polarizabilities 
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SCH-3: Valence cluster, order 3 
PetitjeanNumber. is the petitjean Number descriptor 
 
Conclusion 
 A quantitative structure-activity relationships (QSAR) study on a set 
of 36 structurally-similar 8-methylquinolone analogs was performed using a 
comprehensive set of theoretical molecular descriptors. The GA-MLR 
method was employed for the construction of a robust model for prediction 
of the inhibitory activity (pMIC) against M. tuberculosis. The best regression 
equation was obtained on the following descriptors AATSC, MATS4c 
,VE3_Dzp ,SCH-3 ,PetitjeanNumber. The robustness and the predictive 
ability of the model were verified using a method for internal validation 
(cross-validation leave-one-out) and Y-Randomization. The predictive power 
of the model was tested through the extrapolation of the model over the 
external previously excluded validation data set. The result obtained in this 
study (R2Pred = 0.7393) suggests that the QSAR model can be used to predict 
the pMIC  of novel 8-methylquinolone analogs which fall within the 
applicability domain of the model, before synthesizing them.  
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